Clindamycin Phosphate

Product NDC
51672-4194
11-digit product format
516724194
Labeler code
51672
Product ID
51672-4194_357bd300-1ff2-4c79-8310-21c1da2fd8d8
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Clindamycin Phosphate
Dosage form
AEROSOL, FOAM
Route
TOPICAL
Labeler
Taro Pharmaceuticals U.S.A., Inc.
Application
ANDA210004
Marketing category
ANDA
Marketing start
2022-10-01
Substance
CLINDAMYCIN PHOSPHATE
Active strength
10 mg/g
Pharmacologic classes
Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
EH6D7113I8CLINDAMYCIN PHOSPHATE24729-96-2CLINDAMYCIN PHOSPHATE

Packages

Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
51672-4194-3516724194031 CAN in 1 CARTON (51672-4194-3) / 50 g in 1 CAN1 can2022-10-01NoNoHistorical
51672-4194-7516724194071 CAN in 1 CARTON (51672-4194-7) / 100 g in 1 CAN1 can2022-10-01NoNoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
Clindamycin PhosphateTaro Pharmaceuticals U.S.A., Inc. | Taro Pharmaceutical Industries, Ltd.2022-10-11HUMAN PRESCRIPTION DRUG LABEL3